New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...

Move comes 2 years after controversial exit of brand-name product ...

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma inhalers, are not associated with more severe reactions during oral food ...

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...

I discovered my $600 asthma medication cost only 30 euros in Italy, revealing how Trump's TrumpRx could fix America's broken ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

A Professor of Medicine at the Lagos State University, LASU, Ojo, Professor Olufunke Olayinka Adeyeye, has said no fewer than 13 million Nigerians suffer from Asthma, a respiratory disease.

Pollen allergies are getting worse across the country, according to the Asthma and Allergy Foundation of America’s 2026 “Allergy Capitals: The Most Challenging Places to Live with Allergies” report.

Sometimes the story can be told in statistics. India accounts for 13% of the global population, yet it accounts for 42% of global asthma mortality. Around 35 million Indians are thought to be living ...

Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...